Ignite Creation Date:
2024-05-06 @ 1:51 PM
Last Modification Date:
2024-10-26 @ 1:21 PM
Study NCT ID:
NCT04144517
Status:
COMPLETED
Last Update Posted:
2024-01-25
First Post:
2019-10-24
Brief Title:
A Study of ALKS 4230 Nemvaleukin Alfa With Pembrolizumab in Head and Neck Cancer
Sponsor:
Organization:
Mural Oncology Inc